PDB Short entry for 3SBU HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 06-JUN-11 3SBU TITLE CRYSTAL STRUCTURE OF A NTF2-LIKE PROTEIN (BF2862) FROM BACTEROIDES TITLE 2 FRAGILIS NCTC 9343 AT 2.15 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL NTF2-LIKE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES FRAGILIS; SOURCE 3 ORGANISM_TAXID: 272559; SOURCE 4 STRAIN: NCTC 9343; SOURCE 5 GENE: BF2862; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS CYSTATIN-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN KEYWDS 3 FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3SBU 1 REMARK SEQADV LINK REVDAT 4 24-JAN-18 3SBU 1 JRNL REVDAT 3 25-OCT-17 3SBU 1 REMARK REVDAT 2 24-DEC-14 3SBU 1 TITLE REVDAT 1 13-JUL-11 3SBU 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A HYPOTHETICAL NTF2-LIKE PROTEIN JRNL TITL 2 (BF2862) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.15 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 38908 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1951 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2853 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2074 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2703 REMARK 3 BIN R VALUE (WORKING SET) : 0.2074 REMARK 3 BIN FREE R VALUE : 0.2074 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3836 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.48350 REMARK 3 B22 (A**2) : -1.48350 REMARK 3 B33 (A**2) : 2.96690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4119 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5592 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1800 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 133 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 594 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4119 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 505 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4389 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.33 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.79 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|55 - 284 } REMARK 3 ORIGIN FOR THE GROUP (A): 20.1945 22.5016 -28.8527 REMARK 3 T TENSOR REMARK 3 T11: -0.1226 T22: -0.2047 REMARK 3 T33: -0.0812 T12: 0.0782 REMARK 3 T13: 0.1460 T23: 0.0334 REMARK 3 L TENSOR REMARK 3 L11: 2.9962 L22: 1.1303 REMARK 3 L33: 3.4800 L12: 0.3398 REMARK 3 L13: -1.6665 L23: 0.9706 REMARK 3 S TENSOR REMARK 3 S11: -0.4471 S12: 0.0377 S13: -0.7066 REMARK 3 S21: 0.0707 S22: -0.0054 S23: -0.1449 REMARK 3 S31: 0.5478 S32: 0.0347 S33: 0.4525 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|55 - 284 } REMARK 3 ORIGIN FOR THE GROUP (A): 38.1479 31.6014 7.9583 REMARK 3 T TENSOR REMARK 3 T11: -0.2528 T22: -0.0099 REMARK 3 T33: -0.1996 T12: 0.0087 REMARK 3 T13: -0.0251 T23: 0.0153 REMARK 3 L TENSOR REMARK 3 L11: 3.4339 L22: 2.4842 REMARK 3 L33: 2.6024 L12: -0.2228 REMARK 3 L13: 0.5060 L23: -1.1489 REMARK 3 S TENSOR REMARK 3 S11: -0.1120 S12: -0.0789 S13: 0.1812 REMARK 3 S21: 0.1021 S22: 0.0783 S23: 0.4301 REMARK 3 S31: -0.2643 S32: -0.5524 S33: 0.0337 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. GOL, PEG MODELED ARE PRESENT IN PROTEIN/ REMARK 3 CRYSTALLIZATION/ CRYO CONDITIONS. 4. NON-CRYSTALLOGRAPHIC REMARK 3 RESTRAINTS WERE APPLIED DURING REFINEMENT (LSSR). 5. THE REMARK 3 STRUCTURE WAS SOLVED BASED ON MAD PHASES OF ANOTHER CRYSTAL. REMARK 3 REFINEMENT WAS RESTRAINED BY EXPERIMENTAL PHASES. 6. THE REMARK 3 PROTEIN WAS SUBJECTED TO REDUCTIVE METHYLATION PRIOR TO REMARK 3 CRYSTALLIZATION. ALL LYSINES HAVE BEEN MODELED AS REMARK 3 N-DIMETHYL-LYSINE (MLY) EXCEPT LYSINE 250 WHICH APPEARS TO REMARK 3 HAVE BEEN PROTECTED FROM METHYLATION. REMARK 4 REMARK 4 3SBU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000066013. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-11; 11-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SSRL; SSRL REMARK 200 BEAMLINE : BL14-1; BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000; 0.91162,0.97930 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111); DOUBLE REMARK 200 CRYSTAL REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR; DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR; REMARK 200 DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD; MARMOSAIC REMARK 200 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38981 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 29.591 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.81800 REMARK 200 R SYM FOR SHELL (I) : 0.81800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE CRYSTAL USED FOR 2 WAVELENGTH MAD PHASING DIFFRACTED REMARK 200 TO 2.4 A RESOLUTION. DATA FROM ANOTHER CRYSTAL DIFFRACTING TO REMARK 200 2.15 A WAS USED FOR REFINEMENT. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30.0% GLYCEROL, 5.6% POLYETHYLENE REMARK 280 GLYCOL 4000, 1.0M LITHIUM CHLORIDE, 0.1M SODIUM CITRATE PH 5.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, NANODROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.36533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 130.73067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 98.04800 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 163.41333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.68267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY SUGGESTS A DIMER REMARK 300 IN SOLUTION, THE BIOLOGICAL SIGNIFICANCE OF THE DIMER IS NOT CLEAR. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 40.24250 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 69.70205 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -65.36533 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ALA A 25 REMARK 465 ASP A 26 REMARK 465 PRO A 27 REMARK 465 PHE A 28 REMARK 465 ALA A 29 REMARK 465 SER A 30 REMARK 465 ILE A 31 REMARK 465 THR A 32 REMARK 465 HIS A 33 REMARK 465 LEU A 34 REMARK 465 VAL A 35 REMARK 465 ASP A 36 REMARK 465 SER A 37 REMARK 465 ALA A 38 REMARK 465 MSE A 39 REMARK 465 VAL A 40 REMARK 465 ASN A 41 REMARK 465 MLY A 42 REMARK 465 THR A 43 REMARK 465 ASP A 44 REMARK 465 SER A 45 REMARK 465 ILE A 46 REMARK 465 ASP A 47 REMARK 465 ARG A 48 REMARK 465 GLU A 49 REMARK 465 MLY A 50 REMARK 465 THR A 51 REMARK 465 SER A 52 REMARK 465 ASP A 53 REMARK 465 GLU A 54 REMARK 465 GLY B 0 REMARK 465 ALA B 25 REMARK 465 ASP B 26 REMARK 465 PRO B 27 REMARK 465 PHE B 28 REMARK 465 ALA B 29 REMARK 465 SER B 30 REMARK 465 ILE B 31 REMARK 465 THR B 32 REMARK 465 HIS B 33 REMARK 465 LEU B 34 REMARK 465 VAL B 35 REMARK 465 ASP B 36 REMARK 465 SER B 37 REMARK 465 ALA B 38 REMARK 465 MSE B 39 REMARK 465 VAL B 40 REMARK 465 ASN B 41 REMARK 465 MLY B 42 REMARK 465 THR B 43 REMARK 465 ASP B 44 REMARK 465 SER B 45 REMARK 465 ILE B 46 REMARK 465 ASP B 47 REMARK 465 ARG B 48 REMARK 465 GLU B 49 REMARK 465 MLY B 50 REMARK 465 THR B 51 REMARK 465 SER B 52 REMARK 465 ASP B 53 REMARK 465 GLU B 54 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MLY A 56 CG CD CE NZ CH1 CH2 REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 80 CD OE1 NE2 REMARK 470 MLY A 100 CG CD CE NZ CH1 CH2 REMARK 470 MLY A 103 CG CD CE NZ CH1 CH2 REMARK 470 MLY A 110 CD CE NZ CH1 CH2 REMARK 470 MLY A 143 CH2 REMARK 470 MLY A 156 CH1 CH2 REMARK 470 PRO B 55 CG CD REMARK 470 MLY B 56 CG CD CE NZ CH1 CH2 REMARK 470 ILE B 58 CG1 CG2 CD1 REMARK 470 GLU B 62 CG CD OE1 OE2 REMARK 470 ARG B 79 CG CD NE CZ NH1 NH2 REMARK 470 MLY B 100 CG CD CE NZ CH1 CH2 REMARK 470 MLY B 103 CG CD CE NZ CH1 CH2 REMARK 470 MLY B 144 CG CD CE NZ CH1 CH2 REMARK 470 MLY B 156 CG CD CE NZ CH1 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE A 124 SE MSE A 124 CE -0.370 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 107 -127.20 50.66 REMARK 500 LEU B 107 -127.47 50.37 REMARK 500 ASN B 243 55.44 -140.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 285 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 289 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 290 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 291 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 293 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 294 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 295 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 286 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 296 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 393201 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT (RESIDUES 25-284) WAS EXPRESSED WITH REMARK 999 AN N-TERMINAL PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMARK 999 REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY REMARK 999 THE TARGET SEQUENCE. 2. THE PROTEIN WAS REDUCTIVELY METHYLATED REMARK 999 PRIOR TO CRYSTALLIZATION. DBREF 3SBU A 25 284 UNP Q5LBG4 Q5LBG4_BACFN 25 284 DBREF 3SBU B 25 284 UNP Q5LBG4 Q5LBG4_BACFN 25 284 SEQADV 3SBU GLY A 0 UNP Q5LBG4 EXPRESSION TAG SEQADV 3SBU GLY B 0 UNP Q5LBG4 EXPRESSION TAG SEQRES 1 A 261 GLY ALA ASP PRO PHE ALA SER ILE THR HIS LEU VAL ASP SEQRES 2 A 261 SER ALA MSE VAL ASN MLY THR ASP SER ILE ASP ARG GLU SEQRES 3 A 261 MLY THR SER ASP GLU PRO MLY PRO ILE GLU ALA ASP GLU SEQRES 4 A 261 SER PHE ASP ASP PHE ILE TYR ASN PHE ALA SER ASP ASP SEQRES 5 A 261 ALA LEU GLN ARG GLN ARG VAL VAL PHE PRO LEU PRO TYR SEQRES 6 A 261 TYR ASN GLY GLU ARG ALA SER MLY ILE ASP ARG MLY TYR SEQRES 7 A 261 TRP MLY HIS ASP ASP LEU PHE ALA MLY GLN SER TYR TYR SEQRES 8 A 261 THR LEU LEU PHE ASP ARG GLU GLU ASP MSE ASP LEU VAL SEQRES 9 A 261 GLY ASP THR SER LEU THR SER VAL GLN VAL GLU TRP ILE SEQRES 10 A 261 PHE VAL MLY MLY ARG MSE VAL MLY MLY TYR TYR PHE GLU SEQRES 11 A 261 ARG ILE MLY GLY ALA TRP MSE LEU GLU ALA ILE ASN LEU SEQRES 12 A 261 ARG PRO ILE GLU GLU ASN GLU ASN GLU ASP PHE VAL GLU SEQRES 13 A 261 PHE PHE GLY HIS PHE ALA THR ASP SER ILE PHE GLN SER SEQRES 14 A 261 ARG ARG ILE ARG GLN PRO LEU VAL PHE VAL THR THR ASP SEQRES 15 A 261 PRO ASP ASP ASP PHE SER ILE LEU GLU THR THR LEU ASP SEQRES 16 A 261 LEU ASN GLN TRP PHE ALA PHE MLY PRO ALA LEU PRO ALA SEQRES 17 A 261 ASP MLY LEU SER ASN ILE ASN TYR GLY GLN GLN ASN ASP SEQRES 18 A 261 ASP ASN ALA SER HIS LYS ILE LEU ALA LEU MLY GLY ILE SEQRES 19 A 261 GLY ASN GLY PHE SER ASN ILE LEU TYR PHE GLN ARG MLY SEQRES 20 A 261 ASP SER GLY TRP GLU LEU TYR MLY PHE GLU ASP THR SER SEQRES 21 A 261 ILE SEQRES 1 B 261 GLY ALA ASP PRO PHE ALA SER ILE THR HIS LEU VAL ASP SEQRES 2 B 261 SER ALA MSE VAL ASN MLY THR ASP SER ILE ASP ARG GLU SEQRES 3 B 261 MLY THR SER ASP GLU PRO MLY PRO ILE GLU ALA ASP GLU SEQRES 4 B 261 SER PHE ASP ASP PHE ILE TYR ASN PHE ALA SER ASP ASP SEQRES 5 B 261 ALA LEU GLN ARG GLN ARG VAL VAL PHE PRO LEU PRO TYR SEQRES 6 B 261 TYR ASN GLY GLU ARG ALA SER MLY ILE ASP ARG MLY TYR SEQRES 7 B 261 TRP MLY HIS ASP ASP LEU PHE ALA MLY GLN SER TYR TYR SEQRES 8 B 261 THR LEU LEU PHE ASP ARG GLU GLU ASP MSE ASP LEU VAL SEQRES 9 B 261 GLY ASP THR SER LEU THR SER VAL GLN VAL GLU TRP ILE SEQRES 10 B 261 PHE VAL MLY MLY ARG MSE VAL MLY MLY TYR TYR PHE GLU SEQRES 11 B 261 ARG ILE MLY GLY ALA TRP MSE LEU GLU ALA ILE ASN LEU SEQRES 12 B 261 ARG PRO ILE GLU GLU ASN GLU ASN GLU ASP PHE VAL GLU SEQRES 13 B 261 PHE PHE GLY HIS PHE ALA THR ASP SER ILE PHE GLN SER SEQRES 14 B 261 ARG ARG ILE ARG GLN PRO LEU VAL PHE VAL THR THR ASP SEQRES 15 B 261 PRO ASP ASP ASP PHE SER ILE LEU GLU THR THR LEU ASP SEQRES 16 B 261 LEU ASN GLN TRP PHE ALA PHE MLY PRO ALA LEU PRO ALA SEQRES 17 B 261 ASP MLY LEU SER ASN ILE ASN TYR GLY GLN GLN ASN ASP SEQRES 18 B 261 ASP ASN ALA SER HIS LYS ILE LEU ALA LEU MLY GLY ILE SEQRES 19 B 261 GLY ASN GLY PHE SER ASN ILE LEU TYR PHE GLN ARG MLY SEQRES 20 B 261 ASP SER GLY TRP GLU LEU TYR MLY PHE GLU ASP THR SER SEQRES 21 B 261 ILE MODRES 3SBU MLY A 56 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 96 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 100 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 103 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 110 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE A 124 MET SELENOMETHIONINE MODRES 3SBU MLY A 143 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 144 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE A 146 MET SELENOMETHIONINE MODRES 3SBU MLY A 148 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 149 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 156 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE A 160 MET SELENOMETHIONINE MODRES 3SBU MLY A 226 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 233 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 255 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 270 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY A 278 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 56 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 96 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 100 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 103 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 110 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE B 124 MET SELENOMETHIONINE MODRES 3SBU MLY B 143 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 144 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE B 146 MET SELENOMETHIONINE MODRES 3SBU MLY B 148 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 149 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 156 LYS N-DIMETHYL-LYSINE MODRES 3SBU MSE B 160 MET SELENOMETHIONINE MODRES 3SBU MLY B 226 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 233 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 255 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 270 LYS N-DIMETHYL-LYSINE MODRES 3SBU MLY B 278 LYS N-DIMETHYL-LYSINE HET MLY A 56 5 HET MLY A 96 11 HET MLY A 100 5 HET MLY A 103 5 HET MLY A 110 6 HET MSE A 124 8 HET MLY A 143 10 HET MLY A 144 11 HET MSE A 146 8 HET MLY A 148 11 HET MLY A 149 11 HET MLY A 156 9 HET MSE A 160 8 HET MLY A 226 11 HET MLY A 233 11 HET MLY A 255 11 HET MLY A 270 11 HET MLY A 278 11 HET MLY B 56 5 HET MLY B 96 11 HET MLY B 100 5 HET MLY B 103 5 HET MLY B 110 11 HET MSE B 124 8 HET MLY B 143 11 HET MLY B 144 5 HET MSE B 146 8 HET MLY B 148 11 HET MLY B 149 11 HET MLY B 156 5 HET MSE B 160 8 HET MLY B 226 11 HET MLY B 233 11 HET MLY B 255 11 HET MLY B 270 11 HET MLY B 278 11 HET GOL A 285 6 HET GOL A 287 6 HET GOL A 288 6 HET GOL A 289 6 HET GOL A 290 6 HET GOL A 291 6 HET GOL A 292 6 HET PEG A 293 7 HET PEG A 294 7 HET PEG A 295 7 HET GOL B 286 6 HET PEG B 296 7 HETNAM MLY N-DIMETHYL-LYSINE HETNAM MSE SELENOMETHIONINE HETNAM GOL GLYCEROL HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MLY 30(C8 H18 N2 O2) FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 GOL 8(C3 H8 O3) FORMUL 10 PEG 4(C4 H10 O3) FORMUL 15 HOH *158(H2 O) HELIX 1 1 ILE A 58 GLU A 62 5 5 HELIX 2 2 SER A 63 ASP A 74 1 12 HELIX 3 3 ASP A 74 ARG A 81 1 8 HELIX 4 4 ASP A 98 TRP A 102 5 5 HELIX 5 5 ARG A 120 ASP A 129 5 10 HELIX 6 6 ASP A 176 ASP A 187 1 12 HELIX 7 7 ASP A 187 ARG A 194 1 8 HELIX 8 8 ASP A 218 MLY A 226 1 9 HELIX 9 9 ILE B 58 GLU B 62 5 5 HELIX 10 10 SER B 63 ASP B 74 1 12 HELIX 11 11 ASP B 74 VAL B 82 1 9 HELIX 12 12 ASP B 98 TRP B 102 5 5 HELIX 13 13 ARG B 120 ASP B 129 5 10 HELIX 14 14 ASN B 174 ASP B 187 1 14 HELIX 15 15 ASP B 187 ARG B 194 1 8 HELIX 16 16 ASP B 218 MLY B 226 1 9 SHEET 1 A 6 ARG A 93 ILE A 97 0 SHEET 2 A 6 LEU A 86 ASN A 90 -1 N ASN A 90 O ARG A 93 SHEET 3 A 6 ALA A 158 PRO A 168 1 O ILE A 164 N TYR A 89 SHEET 4 A 6 MSE A 146 ILE A 155 -1 N TYR A 151 O GLU A 162 SHEET 5 A 6 SER A 134 PHE A 141 -1 N VAL A 137 O TYR A 150 SHEET 6 A 6 MLY A 233 ASN A 238 -1 O LEU A 234 N ILE A 140 SHEET 1 B 6 TYR A 113 PHE A 118 0 SHEET 2 B 6 HIS A 249 GLY A 256 -1 O ILE A 251 N PHE A 118 SHEET 3 B 6 SER A 262 MLY A 270 -1 O ASN A 263 N LEU A 254 SHEET 4 B 6 GLY A 273 ASP A 281 -1 O MLY A 278 N TYR A 266 SHEET 5 B 6 ILE A 195 ASP A 205 1 N ARG A 196 O LEU A 276 SHEET 6 B 6 ASP A 208 LEU A 217 -1 O THR A 215 N PHE A 201 SHEET 1 C 6 ARG B 93 ILE B 97 0 SHEET 2 C 6 LEU B 86 ASN B 90 -1 N ASN B 90 O ARG B 93 SHEET 3 C 6 ALA B 158 PRO B 168 1 O ILE B 164 N TYR B 89 SHEET 4 C 6 MSE B 146 ILE B 155 -1 N TYR B 151 O GLU B 162 SHEET 5 C 6 SER B 134 PHE B 141 -1 N VAL B 137 O TYR B 150 SHEET 6 C 6 MLY B 233 ASN B 238 -1 O LEU B 234 N ILE B 140 SHEET 1 D 6 TYR B 113 PHE B 118 0 SHEET 2 D 6 HIS B 249 GLY B 256 -1 O ILE B 251 N PHE B 118 SHEET 3 D 6 SER B 262 MLY B 270 -1 O ASN B 263 N LEU B 254 SHEET 4 D 6 GLY B 273 ASP B 281 -1 O GLU B 280 N ILE B 264 SHEET 5 D 6 ILE B 195 ASP B 205 1 N ARG B 196 O LEU B 276 SHEET 6 D 6 ASP B 208 LEU B 217 -1 O THR B 215 N PHE B 201 LINK C PRO A 55 N MLY A 56 1555 1555 1.34 LINK C MLY A 56 N PRO A 57 1555 1555 1.36 LINK C SER A 95 N MLY A 96 1555 1555 1.33 LINK C MLY A 96 N ILE A 97 1555 1555 1.34 LINK C ARG A 99 N MLY A 100 1555 1555 1.34 LINK C MLY A 100 N TYR A 101 1555 1555 1.35 LINK C TRP A 102 N MLY A 103 1555 1555 1.34 LINK C MLY A 103 N HIS A 104 1555 1555 1.35 LINK C ALA A 109 N MLY A 110 1555 1555 1.33 LINK C MLY A 110 N GLN A 111 1555 1555 1.35 LINK C ASP A 123 N MSE A 124 1555 1555 1.34 LINK C MSE A 124 N ASP A 125 1555 1555 1.35 LINK C VAL A 142 N MLY A 143 1555 1555 1.33 LINK C MLY A 143 N MLY A 144 1555 1555 1.33 LINK C MLY A 144 N ARG A 145 1555 1555 1.35 LINK C ARG A 145 N MSE A 146 1555 1555 1.33 LINK C MSE A 146 N VAL A 147 1555 1555 1.35 LINK C VAL A 147 N MLY A 148 1555 1555 1.32 LINK C MLY A 148 N MLY A 149 1555 1555 1.32 LINK C MLY A 149 N TYR A 150 1555 1555 1.33 LINK C ILE A 155 N MLY A 156 1555 1555 1.34 LINK C MLY A 156 N GLY A 157 1555 1555 1.33 LINK C TRP A 159 N MSE A 160 1555 1555 1.34 LINK C MSE A 160 N LEU A 161 1555 1555 1.35 LINK C PHE A 225 N MLY A 226 1555 1555 1.34 LINK C MLY A 226 N PRO A 227 1555 1555 1.34 LINK C ASP A 232 N MLY A 233 1555 1555 1.32 LINK C MLY A 233 N LEU A 234 1555 1555 1.31 LINK C LEU A 254 N MLY A 255 1555 1555 1.34 LINK C MLY A 255 N GLY A 256 1555 1555 1.31 LINK C ARG A 269 N MLY A 270 1555 1555 1.33 LINK C MLY A 270 N ASP A 271 1555 1555 1.34 LINK C TYR A 277 N MLY A 278 1555 1555 1.34 LINK C MLY A 278 N PHE A 279 1555 1555 1.34 LINK C PRO B 55 N MLY B 56 1555 1555 1.34 LINK C MLY B 56 N PRO B 57 1555 1555 1.36 LINK C SER B 95 N MLY B 96 1555 1555 1.34 LINK C MLY B 96 N ILE B 97 1555 1555 1.35 LINK C ARG B 99 N MLY B 100 1555 1555 1.36 LINK C MLY B 100 N TYR B 101 1555 1555 1.35 LINK C TRP B 102 N MLY B 103 1555 1555 1.33 LINK C MLY B 103 N HIS B 104 1555 1555 1.36 LINK C ALA B 109 N MLY B 110 1555 1555 1.34 LINK C MLY B 110 N GLN B 111 1555 1555 1.35 LINK C ASP B 123 N MSE B 124 1555 1555 1.34 LINK C MSE B 124 N ASP B 125 1555 1555 1.35 LINK C VAL B 142 N MLY B 143 1555 1555 1.34 LINK C MLY B 143 N MLY B 144 1555 1555 1.35 LINK C MLY B 144 N ARG B 145 1555 1555 1.34 LINK C ARG B 145 N MSE B 146 1555 1555 1.33 LINK C MSE B 146 N VAL B 147 1555 1555 1.33 LINK C VAL B 147 N MLY B 148 1555 1555 1.34 LINK C MLY B 148 N MLY B 149 1555 1555 1.35 LINK C MLY B 149 N TYR B 150 1555 1555 1.34 LINK C ILE B 155 N MLY B 156 1555 1555 1.35 LINK C MLY B 156 N GLY B 157 1555 1555 1.34 LINK C TRP B 159 N MSE B 160 1555 1555 1.34 LINK C MSE B 160 N LEU B 161 1555 1555 1.35 LINK C PHE B 225 N MLY B 226 1555 1555 1.33 LINK C MLY B 226 N PRO B 227 1555 1555 1.35 LINK C ASP B 232 N MLY B 233 1555 1555 1.32 LINK C MLY B 233 N LEU B 234 1555 1555 1.33 LINK C LEU B 254 N MLY B 255 1555 1555 1.34 LINK C MLY B 255 N GLY B 256 1555 1555 1.33 LINK C ARG B 269 N MLY B 270 1555 1555 1.33 LINK C MLY B 270 N ASP B 271 1555 1555 1.35 LINK C TYR B 277 N MLY B 278 1555 1555 1.34 LINK C MLY B 278 N PHE B 279 1555 1555 1.33 CISPEP 1 PHE A 84 PRO A 85 0 -5.30 CISPEP 2 GLN A 197 PRO A 198 0 -0.18 CISPEP 3 PHE B 84 PRO B 85 0 -2.27 CISPEP 4 GLN B 197 PRO B 198 0 2.29 SITE 1 AC1 4 VAL A 147 GLU A 170 ASN A 243 HOH A 414 SITE 1 AC2 7 ARG A 93 ASP A 125 LEU A 126 ASP A 129 SITE 2 AC2 7 ARG B 196 VAL B 200 HOH B 416 SITE 1 AC3 5 GLU A 175 GLU A 179 PHE A 180 HIS A 183 SITE 2 AC3 5 PHE A 190 SITE 1 AC4 6 SER A 63 PHE A 64 ASP A 65 VAL A 127 SITE 2 AC4 6 ASP A 129 TYR A 239 SITE 1 AC5 4 MLY A 255 SER A 262 ILE A 264 THR A 282 SITE 1 AC6 5 GLY A 91 ASN A 165 ARG A 167 GOL A 292 SITE 2 AC6 5 HOH B 452 SITE 1 AC7 5 TYR A 89 TYR A 151 ASN A 165 ARG A 167 SITE 2 AC7 5 GOL A 291 SITE 1 AC8 4 SER A 112 PRO A 230 MLY A 233 HOH A 437 SITE 1 AC9 5 TRP A 102 MLY A 103 HIS A 104 ASP A 105 SITE 2 AC9 5 ASP A 106 SITE 1 BC1 5 PRO A 206 ASP A 207 PHE B 141 ASP B 232 SITE 2 BC1 5 MLY B 233 SITE 1 BC2 4 SER B 112 ASN B 259 PHE B 261 HOH B 375 SITE 1 BC3 4 GLN B 111 SER B 112 TRP B 139 MLY B 233 CRYST1 80.485 80.485 196.096 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012425 0.007173 0.000000 0.00000 SCALE2 0.000000 0.014347 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005100 0.00000